Bete, Baby Boy B.

HRN: 28-90-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2026
CEFOTAXIME 500MG (VIAL)
04/22/2026
04/29/2026
IV
350mg
Q8H
Scald Burn
Remove - Pending Acceptance
04/22/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
04/22/2026
04/29/2026
TOPICAL
1%
BID
Scald Burn
Remove - Pending Acceptance
04/23/2026
CEFUROXIME 750MG (VIAL)
04/23/2026
04/30/2026
IV
350mg
Q8h
Scald Burn
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: